A subset of the compound repository for lead identification at Biogen Idec was characterized for its chemical stability over a 3-year period. Compounds were stored at 4 °C as 10 mM DMSO stocks, and a small subset of compounds was stored as lyophilized dry films. Compound integrity of 470 discrete compounds (Compound Set I) and 1917 combinatorial chemistryderived compounds (Compound Set II) was evaluated by liquid chromatography/mass spectrometry from the time of acquisition into the library collection and after 3 years of storage. Loss of compound integrity over the 3 years of storage was observed across the 2 subsets tested. Of Compound Set I, 63% of samples retained > 80% purity, whereas 57% of samples from Compound Set II had purity greater than 60%. The stability of the lyophilized samples was superior to the samples stored as DMSO solution. Although storage at 4 °C as DMSO solution was adequate for the majority of compounds, the authors observed and quantified the level of degradation within the compound collection. Their study provides general insight into compound storage and selection of library subsets for future lead identification activities. (Journal of Biomolecular Screening 2006:828-835) 
INTRODUCTION
D RUG DISCOVERY OFTEN USES high-throughput screening (HTS) of large chemical compound collections to identify compounds with desirable lead-like properties. With the advances of combinatorial chemistry techniques, automated compound inventory systems, and various options for synthesis and purchases of commercial compounds, the compound management and maintenance of a large collection has grown to be an integral part of drug discovery. 1, 2 In the pharmaceutical and biotechnology industries, compound management groups are typically organized within drug/lead discovery to facilitate access and tracking of compounds used by HTS. Compound management groups are responsible for managing liquid stocks and inventory of the compound library collection. This infrastructure facilitates the liquid formulation of the chemical collection to be compatible with screening of compounds for biological activity, the tracking of compound supply, and replenishing of compound stocks.
DMSO is the prevalent solvent used within the drug discovery industry because it can dissolve a wide range of compounds. Typically, compounds are stored in microtiter plates/vials. As compound management groups came to recognize the issues of compound storage, several key factors such as temperature, environment controls, and freeze/thaw cycles emerged as the major concerns for DMSO stocks. To cope with these problems, various strategies were developed and adopted across the pharmaceutical and biotechnology industries for storage of their compound solution collections. A common storage condition is at 4 °C, where compounds in DMSO will be frozen with limited water uptake under strict environmental conditions and effective control of DMSO stock storage. Another approach includes the deliberate addition of water into the DMSO stocks to maintain a liquid state and thus to avoid freeze/thaw cycles. Yet other approaches are to store the compound collection either at -20 °C or at -80 °C to ensure the compound collection is frozen. 1, [3] [4] [5] [6] [7] Regardless of long-term storage conditions, compounds may be placed at room temperature for a period of time during processing for sample preparation or to undergo HTS. It is quite common that compounds stored at either 4 °C or -20 °C undergo freeze/thaw cycles during sample preparation for HTS. Furthermore, the hygroscopic DMSO absorbs water, changing the environment of the compound samples. All of these components of compound management have raised concerns of compound integrity. Pressure to succeed in HTS has made compound quality a focal point, in addition to questions of chemical diversities and the size of the compound collection. Thus, the issues of chemical stability under liquid storage conditions have received greater attention within drug discovery in recent years. Although the challenges of maintaining compound integrity of large libraries have been discussed in several conferences, there have been a limited number of reports in the literature. [6] [7] [8] [9] [10] [11] These publications investigate the effects of several aspects of compound storage conditions, such as storage temperature, solvent, containers, and freeze/thaw cycles, on compound stability. Kozikowski et al. 12 monitored the stability of ~7.2 K compounds stored as 20 mM DMSO stocks under ambient conditions for 12 months. They reported that the probability of identifying a given compound decreased over time: from 92% at 3 months to 52% at the end of the study. In another study conducted by Kozikowski and coworkers, 13 a smaller collection of compounds (n = 320) stored as 20 mM DMSO stocks at 4 °C in low humidity was evaluated for the effect of numerous freeze/thaw cycles. Fifteen cycles of freeze/thaw led to loss of integrity of ~25% of the compound collection. The data were used to generate a prediction model for the stability of compounds and thus the retention of solution stocks in the collection. Cheng et al. 14 investigated the stability of 644 compounds stored as 10 mM DMSO stocks under several temperature, atmospheric, and storage vessel scenarios. No significant impact on compound stability was observed with 11 freeze/thaw cycles or the vessel used (glass or polypropylene). However, their results showed the deleterious effect of water on compound stability. Schopfer and coworkers 6 summarized the strategies at Novartis Institute of Biomedical Research to cope with the compound storage issues and the effects of water in DMSO stocks on compound stability and solubility.
The main effects of water in compound DMSO stocks are well summarized by Lipinski 15 and Oldenburg et al. 16 : 1) the melting point declines, 2) viscosity increases, and 3) the solvent is more structured, resulting in the formation of ice-1-like hydrogen bonding lattices. These changes can have profound effects on compound solubility and stability. The compound concentration changes due to the water uptake. This adds an unwanted variable in determining the compound dose for testing. The compound may precipitate from the DMSO stock, causing deleterious effects on the assay, leading to unreliable test results. Difficulty in dissolving a large lipophilic compound will affect compound handling for HTS as dilutions are often necessary to prepare samples at a given dose within an HTS assay. The impact of compound quality on the success of HTS is obvious; the integrity of compounds is directly linked to the quality of biological screening results. For example, false negatives and positives will confuse knowledge-driven efforts or early stage structure-activity relationships (SAR) because similar structures could show very different patterns of biological activities. Typically, drug discovery efforts have chosen to avoid the identification of putative active compounds generated by storage degradation due to the high cost in time and resources.
HTS was initiated at Biogen Idec (BIIB) in 1998. A large number of compounds were purchased from 1999 and 2000 with a final compound repository of more than 500 K. In an effort to consolidate the compound library collection and implement new screening strategies that emphasize testing of small compound collections, compound integrity was evaluated as a first step in reducing the overall compound library size. Due to the size of the compound collection and the prohibitive cost associated with quality control testing of the entire compound collection, a subset of the compound collection was identified and tested for sample integrity. The results were compared to historical purity data and the compound acquisition criteria used when the compound collection was originally assembled. The primary goal of the study was to obtain a quantitative measure of the integrity of the compound collection. In turn, results can be incorporated into a drug discovery strategy for condensing and testing the library for lead identification. It is beyond the scope of this study to explore all the causes and explanations of compound instability. However, the study provides useful information to guide similar studies in other laboratories also striving to gain a better understanding of their compound collection. Our study quantifies the impact of compound storage specific to conditions adopted by BIIB in 1998 and provides insight to improving storage and to understanding compound stability and degradation.
MATERIALS AND METHODS

Compound library and storage
The compound collection consisted of ~400 K compounds generated by combinatorial chemistry synthetic routes and 130 K compounds generated as discrete chemical entities from various commercial suppliers. Upon acquisition, compounds were placed into 100% DMSO at an initial concentration of 10 mM. A small subset of the compounds (< 1%) was lyophilized shortly after the initial DMSO phase. All of the compound plates were stored in polypropylene deep-well blocks at 4 °C without humidity controls.
Sample selection of discrete chemical compound collection
The 470 (~0.4% of the collection) compounds for purity analysis from the noncombinatorial source were originally chosen at random upon acquisition. The same collection of compounds was used for the 3-year stability analysis and termed as Compound Set I (Cmpd Set I).
Compounds from the combinatorial source were first filtered from the database using Pipeline Pilot™ (Scitegic, Inc., San Diego, CA, version 3.0.1.0) on the basis of structural and physical property diversity using extended connectivity fingerprints (ECFPs), molecular weight, and log P. A 2D structure database of the compound library was generated, and compounds containing sulfates and phosphates were removed from selection. In total, 1,917 (~0.5% of the collection) compounds for purity analysis were chosen and termed as Compound Set II. The compounds were from 42 sublibraries, and each sublibrary was represented within the testing collection. The number of compounds from each sublibrary was proportional to the whole collection and ranked by the number of compounds per archive plate present, with compounds chosen from the beginning, middle, and end of each list. A 96-well plate containing 80 lyophilized compounds was also chosen to compare the effects of storage conditions of lyophilized compounds and DMSO solutions. These 80 compounds represent 12 distinct sublibraries and were resuspended in 100% DMSO at the concentration of 10 mM after 3-year storage.
Liquid chromatography/mass spectrometry
The compounds for analysis were diluted with H 2 O: ACN (v/v 30:70) to a final concentration of 50 µg/mL. Then, 100 µL of diluted samples was transferred into Falcon polypropylene 96-well microplates, and 30 µL of each sample was injected into a Waters 2790 HPLC equipped with a Waters 996 photo diode array detector (PDA). High-performance liquid chromatography (HPLC) was coupled to a Waters Quattro Ultima triple quadrupole mass spectrometer. The samples were separated over a Waters Xterra MS C18 column (2.1 × 50 mm), and gradient was eluted from 10% solvent A (see below) to 90% B (see below) in 4 min.
At the beginning of the study, the samples from Compound Set I were kept at room temperature during liquid chromatography/mass spectrometry (LC/MS) analyses and injected manually: the flow rate was 1.5 mL/min with 100% water as solvent A and 100% acetonitrile as solvent B.
At the end of the study, the compound samples were kept at 4 °C and were injected using a Water 2795 autosampler for Compound Sets I and II. The flow rate was 400 µL/min with 100% water and 1% formic acid as solvent A. The solvent B is 100% methanol and 1% formic acid. The modification of the method at the end of the study was to improve the separation.
A PDA detector scanned the wavelength from 210 to 400 nm at a sampling rate of 1 scan per second. The mass spectrometer equipped with ESI source was operated in the positive centroid mode. The MS scan range was z 110-1000 Da at 1.0 sec per scan. The data were acquired using Micromass MassLynx™ software. The resulting files were analyzed using Micromass OpenLynx™ software. MS data were reported based on the peaks detected in PDA chromatograms in the wavelength range of 260 to 320 nm. Reconstructed ion chromatograms (RIC) corresponding to the expected (M+H) + were generated. If a PDA peak was detected at the same retention time as an RIC peak, then the expected compound was detected. The purity percentage was calculated from PDA chromatograms, and the calculation was performed using OpenLynx™.
The compound purity for Compound Set II was determined by the vendor at the time of synthesis and met the criteria of greater or equal to 85% purity.
The data analysis was performed using Spotfire™ and Prism™.
RESULTS AND DISCUSSIONS
The general timeline and scheme of the study are shown in Figure 1 . Compound integrity from 2 collections was evaluated after a 3-year storage period. The goal of this study was to assess the stability of compounds under our library storage conditions and use the data generated to implement a strategic approach toward condensing the library collection for focused screening efforts. For the purpose of this study, compounds originating from noncombinatorial methods were defined as Compound Set I, and compounds originating from combinatorial synthetic methods were defined as Compound Set II. The sample size chosen represents 0.4% and 0.5% of the discrete collection and combinatorial collections, respectively. The total number of compounds chosen was based on diversity analysis and in-house ability for throughput of purity assessment. A set of 470 compounds from various vendors (Compound Set I) was tested at the beginning and end of the study. A set of 1927 compounds from combinatorial synthesis (Compound Set II) was tested at the end of the study and benchmarked against purity quality control criteria set as acceptable for successful synthesis (> 85% at the beginning of the study). Representative LC/MS data are shown for a compound that degraded to 33% from 100% ( Fig. 2A,B ) and a compound that maintained 100% integrity after 3-year storage (Fig. 2C,D) .
Data analysis: Compound Set I
Of the 470 compounds analyzed at the beginning of the study, 94% had a purity of 80% or greater, with an average purity of 88% (Fig. 3A) . These data were used as the baseline of the original purities of the compounds. When the same set of compounds was measured again at the end of the study, 63% of the compounds were found to have a purity of 80% or greater, with an average purity of 68% (Fig. 3B ).
Data analysis: Compound Set II
Of the 1917 compounds, compound purity was of 85% or greater purity at the time of synthesis. At the end of the study, 57% of the compounds had a purity of 60% or greater, with an average purity of 61% ( Fig. 4) . Of the compounds, 23% analyzed were either not present or the expected mass was not detected. The data are indicative of compounds that have degraded into another compound species, precipitated in methanol during analysis/in DMSO stocks, or their original synthesis was incomplete.
The results showed that the overall stability of the discrete compound set was greater than the combinatorial compound set after the 3-year storage period. When considering the entire compound data set, an overall loss of compound purity was observed. However, we found that the majority of compounds in both collections retained purity > 60%: 63% for Compound Set I and 57% for Compound Set II. The combinatorial compound collection suffered greater loss as shown by the distribution of compounds over purity ranges: 0% to 20% pure (22% of compounds, n = 433), 20% to 40% pure (7% of compounds, n = 137), 41% to 60% pure (13% of compounds, n = 252), 61% to 80% pure (14% of compounds, n = 269), and 81% to 100% pure (43% of compounds, n = 826). In contrast, Compound Set I either showed a significant loss in compound, or compound was largely retained: 0% to 20% pure (37% of compounds, n = 128) and 80% to 100% (63% of compounds, n = 296). The data are consistent with previous reports on compound stability. 12, 13 Compound degradation may be caused by steps inherent to the process of storage or by properties inherent to the compounds themselves. We analyzed the role of plate location on compound stability, which is a feature of storage that can be modified when considering alternative storage options. We also analyzed the role of molecular weight (MW) of the compound on stability, an inherent physical property of a compound. No correlation was observed with MW and compound stability from either Compound Set I or II (Fig. 5) . Compound degradation could not be associated with a specific molecular weight range of our compound collection. Compound Set II, which showed greater degradation than Compound Set I, was used to evaluate the effect of compound location on a storage plate. Compounds were identified from the outer wells of the 96-well storage plate and from the interior of the storage plate. Outer wells were defined as columns 1, 2, 11, 12 and rows A, B, G, H of the deep-well storage plates. The remaining wells of the plate were defined as the inner wells of the storage plate. No correlation was observed with location of the outer and inner wells of the storage plate and compound stability for Compound Set I (data not shown) or Compound Set II (Fig. 6) . The effect of water incorporation into DMSO stocks was investigated by the comparison of DMSO stocks and lyophilized stocks because lyophilization storage would circumvent the inclusion of water. We observed an increased volume of DMSO compound stocks in the 96-well storage plates while the lyophilization compounds were still in the state of dry films. The samples within the DMSO compound plates were no longer frozen at 4 °C and -20 °C. These observations likely correlate with a limitation of our storage environment, which does not prevent water uptake. Water content in these samples is greater than 10% based on their liquid state at -20 °C. 6, 7, 15, 17 A set of compounds (n = 80) representing 12 distinct sublibraries from Compound Set II, stored as both lyophilized powder and DMSO at 4 °C conditions, was characterized for their stability, and the results are shown in Figure 7 . Compound stability of the lyophilized samples was clearly superior to samples stored as DMSO stocks. Of the lyophilized compounds, 93% retained purity of 80% to 100% at the end of the study. In contrast, analysis of the same compounds stored in DMSO indicated that only 63% of the compounds retained purity of 80% to 100%.
Another major effect of water in DMSO samples is precipitation of compound from solution and is a possible cause of loss of compound purity in our analysis. 6, 7, 16 We have observed, within the compound collection, crystallized or deposited samples at the bottom of wells. Although the sonication method developed by MatriCal could aid in the resolubilization of compound into solution (10 of 34 compounds were fully or partially driven into solution, whereas 4 compounds had increased precipitation), 16 a universal solution for resuspension of compounds in the DMSO-water mix remains to be identified. 7, 16 Having established that most discrete compounds within the library collection were present at high purity, our next step was to determine if we could identify the chemical groups associated with degradation. This information could be useful for identifying an approach to condensing the collection or as a starting point for a global approach to predicting compound behavior in large collections. A Bayesian learning approach was applied to identify the moieties and functional groups most correlated with poor purity in the discrete compound library. The Bayesian learning component based on functional-class fingerprints (FCFPs) implemented in Pipeline Pilot™ was trained using compounds with purity < 80% at the beginning of the study to generate an initial model for poor purity. Although there were a wide variety of moieties identified as correlating to poor purity in the model, examples of compounds containing the most common are depicted in Figure 8A . A second Bayesian model was trained on compounds that had purity > 80% at the beginning of the study and purity < 50% at the end of the study. In this instance, the aim was to identify moieties that correlated to loss over initial purity over time. Many of the same groups identified in the first model were also present in the latter model, including imines and hydrazones. In addition, the groups were correlated to poor purity by the model (Fig. 8B) . It should be noted that the overall diversity of the 470 compounds tested from the discrete collection ensures that no single moiety is dominantly correlated to poor purity. However, within the sample set used, the models suggest that hydrazones and imines are most likely the cause of compound decomposition.
Our study characterized the effects of storage conditions on the BIIB library collection and provides a general overview of assessing compound library quality and predicting degradation patterns to compound management groups within the pharmaceutical and biotechnology industries. These results have allowed us to make informed choices regarding the storage of our compound collection and, subsequently, the prioritization given to screening for lead identification. The purity and integrity data generated for the discrete collection led us to place higher priority for screening of the discrete collection over the combinatorial collection. Although the discrete compound collection, with an average purity of 68%, has degraded since they were acquired, it is our belief that they are of adequate quality and value to use for lead identification purposes. A deciding factor in this assessment was the distribution obtained of the compound purity. Compounds were either shown to be intact or to have completely degraded. Thus, false positives can be eliminated by purity assessment. Limited use of the combinatorial collection, combined with the deleterious effects of water uptake, led us to place the collection in -80 °C for indefinite storage and -20 °C for working stock storage. Clearly, lyophilization of the master stock of a compound collection is preferred to solution storage. However, due to physical laboratory space constraints and the cost associated with the preparation of large compounds collections, lyophilization was not a practical option for us. As we continue to condense the compound collection, our data set evaluating the correlation between the chemical structure and the purity results can be used as a training set to build a model to accurately predict the long-term viability of compound libraries. A more detailed analysis of physical chemical properties (log P, solubility, polarity) will also be useful for establishing a viable model for long-term storage conditions of chemical compound libraries.
CONCLUSIONS
We have quantified the purity and integrity of the BIIB compound collection, which is defined as a discrete collection and a combinatorial collection. We show that the discrete collection has greater purity and integrity relative to the combinatorial condition: 63% compounds within discrete collection have > 80% purity, and 57% of compounds within combinatorial collection have > 60% purity. The goal of our compound stability study was achieved by allowing us to use compound purity and integrity data to prioritize selection of the discrete collection when condensing the BIIB collection for testing purposes. Screening a smaller collection of compounds with greater sample integrity reduces the cost of lead identification by reducing the screening and follow-up time required to confirm the activity of compounds. 
